Microbial Colonization
212
33
47
100
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Research Maturity
100 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.9%
4 terminated out of 212 trials
96.2%
+9.6% vs benchmark
5%
11 trials in Phase 3/4
4%
4 of 100 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 100 completed trials
Clinical Trials (212)
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Minimal Flow Anesthesia and Infection Risk
Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit
Matching Donor Human Milk On Maternal Secretor Status (MMOMSS) Study
FMT for Lung and Associated-organ Rescue Efficacy in MDRO-infected Ventilated Patients
Microbiome Modulation by PEMF on Plaque Induced Mucositis in Human Jaws
Microbiome Derived Metabolism and Pharmacokinetics
Balance, Autonomic Response, and Sensory Modulation to Dosage of Mechanical Vagal Stimulation in Healthy Adults
Microbiome and Malnutrition in Pregnancy
Skin Preparation for Elective Foot and Ankle Surgery
The Role of the Human Microbiome in Patients After Pancreatic Resection.
NICU Antibiotics and Outcomes Trial
Analysis of the Microbiota and STEMI
Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults
Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation
Synbiotics in Patients at RIsk fOr Preterm Birth
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
Comparing Impacts of Donor Human Milk to Formula Supplementation on the Gut Microbiome of Full-term Infants
DOnor Milk to REpair the Full-term Infant MIcrobiome in Infants Born Via Cesarean Section.
Assessment of the Ocular Microbiome in Health and Disease